Carrie D'Andrea
Hoofd Techniek/Wetenschap/O&O bij ACASTI PHARMA INC.
Vermogen: - $ op 30-04-2024
Actieve functies van Carrie D'Andrea
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
ACASTI PHARMA INC. | Hoofd Techniek/Wetenschap/O&O | 08-05-2023 | - |
Loopbaan van Carrie D'Andrea
Eerdere bekende functies van Carrie D'Andrea
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
EryDel SpA
EryDel SpA Medical SpecialtiesHealth Technology EryDel SpA offers medical research. It develops drugs and diagnostics delivered through human red blood cells via a medical device technology. The company was founded by Luigia Rossi and Mauro Magnani in 2007 and is headquartered in Bresso, Italy. | Corporate Officer/Principal | 01-10-2020 | 01-04-2021 |
Edge Therapeutics, Inc.
Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | Hoofd Techniek/Wetenschap/O&O | 01-10-2014 | 01-03-2019 |
Opleiding van Carrie D'Andrea
Temple University (Pennsylvania) | Graduate Degree |
Statistieken
Internationaal
Verenigde Staten | 4 |
Italië | 2 |
Operationeel
Chief Tech/Sci/R&D Officer | 2 |
Graduate Degree | 1 |
Corporate Officer/Principal | 1 |
Sectoraal
Health Technology | 4 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ACASTI PHARMA INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Edge Therapeutics, Inc.
Edge Therapeutics, Inc. BiotechnologyHealth Technology Edge Therapeutics, Inc. is clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of novel, hospital-based therapies capable of transforming treatment paradigms in the management of acute, life-threatening neurological and other conditions. Its product candidate is the EG-1962. The company was founded on January 22, 2009 by Brian A. Leuthner, Robert Loch Macdonald and Carl J. Soranno and is headquartered in Berkeley Heights, NJ. | Health Technology |
EryDel SpA
EryDel SpA Medical SpecialtiesHealth Technology EryDel SpA offers medical research. It develops drugs and diagnostics delivered through human red blood cells via a medical device technology. The company was founded by Luigia Rossi and Mauro Magnani in 2007 and is headquartered in Bresso, Italy. | Health Technology |
- Beurs
- Insiders
- Carrie D'Andrea
- Ervaring